Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.
Elsevier's Gold Standard
, Elsevier's Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Elsevier's Gold Standard solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Elsevier's Gold Standard, visit
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including
, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include
Mosby's Nursing Suite
, which enhance the productivity of science and health professionals, and the
MEDai's Pinpoint Review
, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in
employs 7,000 people worldwide. The company is part of
Reed Elsevier Group PLC
, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164